"Discontinuous" antibiotic therapy for urinary tract infections

Area of Science:

• Pharmacology
• Infectious Diseases
• Clinical Pharmacy

Background:

• Antibiotic dosing frequency is often based on tradition rather than evidence.
• Frequent antibiotic administration can negatively impact patient compliance.
• Bactericidal antibiotics may not require four-times-daily dosing.

Purpose of the Study:

• To compare the efficacy and safety of twice-daily versus four-times-daily cephradine for treating urinary tract infections.
• To evaluate the impact of dosing frequency on patient outcomes and compliance.

Main Methods:

• A double-blind study involving 548 patients with urinary tract infections.
• Comparison of oral cephradine 1g twice daily (b.i.d.) versus 500mg four times daily (q.i.d.).
• Assessment of patient response rates and incidence of adverse reactions.

Main Results:

• Both cephradine regimens demonstrated equivalent efficacy, with 89% of patients responding well and rapidly in each group.
• The incidence of cephradine-related adverse reactions was similar between the twice-daily and four-times-daily dosing groups.
• The study suggests simplified dosing does not compromise treatment outcomes.

Conclusions:

• Twice-daily oral cephradine is a viable alternative to four-times-daily dosing for urinary tract infections.
• Simplified antibiotic regimens can maintain therapeutic efficacy and safety.
• Reducing dosing frequency may improve patient compliance and adherence to treatment.